SEC Form 4 · accession 0001123292-15-000992
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin M Berger
Director
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2015 | M | 4,065 | $5.54 | A | 50,821 | D | |
| Common Stock | Jul 1, 2015 | M | 2,439 | $6.89 | A | 53,260 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) | $5.54 | Jul 1, 2015 | M | 4,065 | D | Jul 12, 2012 | Jul 10, 2022 | Common Stock | 4,065 | 0 | D |
| Stock Option (right to buy) | $6.89 | Jul 1, 2015 | M | 2,439 | D | Aug 23, 2011 | Oct 27, 2020 | Common Stock | 2,439 | 0 | D |